Humalog Mix 25 in the treatment of type 2 diabetes mellitus

Abstract

Diabetes mellitus type 2 remains one of the most significant chronic diseases. More than 552 million individuals (one of every teninhabitants of the planet) are estimated to have diabetes mellitus to 2030. Early incapacitation and high mortality rates resulting fromlong-term diabetes complications constitute social significance of carbohydrate metabolism disorders. Despite modern advances intreatment, most diabetic patients are not adequately compensated, requiring intensification of insulin therapy. Pre-mixed insulins areone of the most advanced options of treatment intensification.